Year To Quarter End Statement Of Income

Oncolys BioPharma Inc. - Filing #7712867

Concept 2017-01-01 to
2017-09-30
2017-01-01 to
2017-09-30
2017-01-01 to
2017-09-30
2017-01-01 to
2017-09-30
2017-01-01 to
2017-09-30
2016-01-01 to
2016-09-30
2016-01-01 to
2016-09-30
2016-01-01 to
2016-09-30
2016-01-01 to
2016-09-30
2016-01-01 to
2016-09-30
Year to quarter end statement of income
Statement of income
Net sales
JPY
29,027,000 JPY
19,904,000 JPY
9,122,000 JPY
29,027,000 JPY
46,540,000 JPY
46,540,000 JPY
JPY
46,540,000 JPY
JPY
Cost of sales
3,968,000 JPY
8,000 JPY
Gross profit (loss)
25,058,000 JPY
46,532,000 JPY
Selling, general and administrative expenses
793,475,000 JPY
726,089,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-396,909,000 JPY
-371,507,000 JPY
-83,485,000 JPY
-288,022,000 JPY
-768,416,000 JPY
-84,907,000 JPY
-679,556,000 JPY
-305,549,000 JPY
-374,006,000 JPY
-289,099,000 JPY
Non-operating income
Interest income
2,964,000 JPY
3,999,000 JPY
Dividend income
4,000 JPY
4,000 JPY
Non-operating income
2,997,000 JPY
12,662,000 JPY
Non-operating expenses
Interest expenses
2,454,000 JPY
2,487,000 JPY
Non-operating expenses
11,363,000 JPY
15,769,000 JPY
Ordinary profit (loss)
-776,782,000 JPY
-682,662,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
120,000 JPY
Extraordinary income
JPY
120,000 JPY
Extraordinary losses
Impairment losses
JPY
47,353,000 JPY
Extraordinary losses
JPY
47,353,000 JPY
Profit (loss) before income taxes
-776,782,000 JPY
-729,895,000 JPY
Income taxes - current
2,578,000 JPY
1,654,000 JPY
Income taxes
2,578,000 JPY
1,654,000 JPY
Profit (loss)
-779,361,000 JPY
-731,550,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.